Speech-Language Pathologists in Paris, MO Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Kristen Gholson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 South St, Paris, MO 65275 Phone: 660-327-4125 |
Becky S Blackaby, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 740 Cleveland St, Paris, MO 65275 Phone: 660-327-5116 Fax: 660-327-4290 |
Katelin Moore Worthington, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Monroe Manor 200 Sout St, Paris, MO 65275 Phone: 660-327-4125 Fax: 660-327-5264 |
Mrs. Elizabeth Black Wyant, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 23835 Highway 24, Paris, MO 65275 Phone: 660-327-1402 Fax: 660-327-1403 |
News Archive
Mapping the dominance of the SARS-CoV-2 UK variant in Europe
A research paper recently uploaded to the preprint server medRxiv* by Vespignani et al. (February 22nd, 2021) uses mathematical models to map the spread of this lineage across Europe, establishing that a 50% increase to the transmissibility of the variant would allow it to become dominant in major metropolitan areas by the end of March 2021.
Yale researchers develop new mouse model to study SARS-CoV-2 infection
Researchers at Yale University School of Medicine have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.
A polyphenols-rich diet keeps the heart younger
This finding comes out from a study by the University of Grenoble in collaboration with the other Centres participating to the FLORA Project, a European Commission funded research studying the effects of flavonoids, a variety of polyphenols, on human health.
South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection
A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to the final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.
› Verified 1 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists